Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now includes a consolidated Locations section listing California, Connecticut, Florida, Illinois, Massachusetts, Michigan, Missouri, New Jersey, New York, North Carolina, Tennessee, and Washington, with a new revision tag v3.3.3. The previous state-specific location sections and the HHS Vulnerability Disclosure link have been removed, and the Revision tag changed from v3.3.2.
    Difference
    1%
    Check dated 2025-12-23T20:41:39.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a new Revision: v3.3.2 and removed Revision: v3.2.0 in the page's release notes area.
    Difference
    0.0%
    Check dated 2025-11-25T10:48:38.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Deletion of the government funding notice banner; a general site status message that does not affect the trial details.
    Difference
    0.3%
    Check dated 2025-11-18T06:56:32.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    No core content, eligibility criteria, or study design changes were observed; only updates to metadata such as the last update date are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:03:55.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added new dates (2025-10-08, 2025-11-30, 2025-10-07) and removed older dates (2025-09-10, 2025-08-30, 2025-09-08). This indicates updated timing information but no changes to core content or pricing.
    Difference
    0.4%
    Check dated 2025-10-13T08:36:44.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T05:36:38.000Z thumbnail image

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.